- InspireMD (NASDAQ:NSPR) Q4 results: Revenues: $0.5M (-44.4%); R&D Expense: $0.8M (-46.7%); SG&A: $1.7M (-48.5%); Operating Loss: ($2.6M) (+40.9%); Net Loss: ($2.9M) (+39.6%); Loss Per Share: ($0.37) (+68.9%); Non-GAAP Loss Per Share: ($0.31) (-67.0%).
-
FY2015 results: Revenues: $2.3M (-17.9%); R&D Expense: $3.6M (-58.6%); SG&A: $9.6M (-38.9%); Operating Loss: ($14.5M) (+38.8%); Net Loss: ($15.6M) (+37.8%); Loss Per Share: ($2.23) (+68.5%); Non-GAAP Loss Per Share: ($1.69) (+71.4%); Quick Assets: $3.3M (-47.6%).
- No guidance given.